-
2 months ago | 
cellandgene.com | Matthew Pillar |Raul P. Lima |inSeption Group |Lakshmi Guduri
Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte.
-
Feb 4, 2025 | 
outsourcedpharma.com | Louis Garguilo |Raul P. Lima |inSeption Group |Joonman Hong
Webinar: From Research to Reality: Overcoming CMC Challenges in Cell & Gene TherapyJoin us on February 20th to learn how to overcome manufacturing and regulatory challenges in cell and gene therapy by developing robust CMC strategies, employing Quality by Design, and implementing phase-appropriate GMP processes. This webinar is ideal for small biopharma companies and institutions seeking to bridge research and commercial development effectively. Click here to learn more.
-
Dec 4, 2024 | 
outsourcedpharma.com | Louis Garguilo |William Powers |Jenny Minigh |inSeption Group
Whitepaper: Nose to Brain (N2B) Drug Delivery – Benefits and Challenges. The brain and central nervous system (CNS) are critical yet challenging targets for drug delivery due to barriers like the blood-brain barrier. Explore the benefits and challenges of Nose to Brain (N2B) delivery, including delivery targets, transport mechanisms, liquid and dry powder formulations, and the development of nasal dosage forms.
-
Dec 4, 2024 | 
clinicalleader.com | Dan Schell |Treating Deficiencies |Jenny Minigh |inSeption Group
Right-sized for biotech successIt's not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We've got you.
-
Nov 6, 2024 | 
clinicalleader.com | Dan Schell |Raul P. Lima |inSeption Group |Cheri Pettey
Digging Through the Hype: Can AI/ML Assist Clinical Development? Join us on November 14th at 11:00am EST to learn approaches to leveraging AI and machine learning when handling clinical data, how to approach the use of Generative AI for analyzing clinical trial data, and how to approach human-in-the-loop data mapping with machine learning. Register here.
-
Oct 22, 2024 | 
outsourcedpharma.com | Louis Garguilo |Raul P. Lima |inSeption Group
Components of the WuXi global organization are for sale. It’s a forced divestiture. WuXi AppTec is marketing some of its U.S. and European operations. The ill-advised BIOSECURE Act targeting several China-based biopharma companies is having its intended effects, even before the legislation is fully passed by the U.S. government. Where do you stand? A Supply-Chain Woman Of IranArezou Mehrabi has a spellbinding supply-chain case study. It transpired, of all places, in Iran.
-
Oct 8, 2024 | 
outsourcedpharma.com | Louis Garguilo |Raul P. Lima |inSeption Group |A Focus
Your Trusted Biologics Testing PartnerSGS Supports biopharmaceutical clients from discovery to clinical development and commercialization, through a comprehensive scope of expert-led quality control testing for raw materials, APIs, and finished products.
-
Sep 11, 2024 | 
outsourcedpharma.com | Louis Garguilo |Jenny Minigh |inSeption Group
Technical Excellence In ADC ManufacturingOn October 24, join industry experts for an exclusive series of cutting-edge presentations on demonstrating technical excellence in process development and manufacturing for ADCs and bioconjugates. Register to gain access to expert knowledge that will drive innovation and accelerate your ADC development and manufacturing program.
-
Aug 1, 2024 | 
cellandgene.com | Erin Harris |Raul P. Lima |inSeption Group |Grant Merrill
Digital Data: Your Roadmap To Supply Chain EfficiencyJoin the eData movement! Learn how life science manufacturers are embracing digital transformation as they see it as the pathway to a patient-focused future of high-quality therapeutics. Learn more. Raj Bandaru, Associate Director in Regulatory Affairs and U.S. Regulatory Affairs Lead at Accenture provides rich context on parts of the recent FDA Draft Guidance, Rare Diseases: Considerations For The Development Of Drugs And Biological Products.
-
Jul 31, 2024 | 
clinicalleader.com | Dan Schell |Jenny Minigh |inSeption Group |Treating Deficiencies
Right-sized for biotech successIt’s not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We’ve got you.
